Nexentis unit MitoCareX evaluates new protein sourcing options for in-vitro research - NXTS News | RalliesNexentis unit MitoCareX evaluates new protein sourcing options for in-vitro research
N
NXTS• MitoCareX reviews protein sourcing options
- Nexentis unit MitoCareX is evaluating additional commercially available approaches to source proteins for in-vitro research.
- Review targets greater flexibility in research materials as MitoCareX advances future in-vitro drug discovery programs.
- Assessment remains early-stage with no assurance any new protein-sourcing approach will be adopted.
•
